STEVEN J. PENNER
|
EDUCATIONAL BACKGROUND:
J.D. University of Colorado School of Law, Boulder CO 2002 Ph.D. University of Michigan Medical School, Ann Arbor, Michigan, Microbiology and Immunology, 1994 M.S. University of Michigan Medical School, Microbiology, 1988 B.S. Iowa State University, Microbiology, 1987 PROFESSIONAL EXPERIENCE: Greenlee Sullivan P.C., Boulder, CO; Associate Attorney, 2002- present Greenlee Sullivan P.C., Boulder, CO; Technical Consultant Jan 2000 - 2002 Proligo LLC, Boulder, Colorado, Corporate Counsel Extern Aug 01-Dec 01 Merchant & Gould, Denver, Colorado, Summer Law Clerk May 01-Aug 01 Greenlee Sullivan, Boulder, Colorado, Summer Law Clerk June 00-May 01 Heska Corporation, Fort Collins, Colorado, Product Development and Regulatory Affairs, Apr 96-Jul 99 Heska Corporation, Fort Collins, Colorado, Scientist, Apr 96-Apr 97 Cortech, Inc., Denver, Colorado, Scientist/Post-Doctoral Research Fellow May 94-Apr 96 University of Michigan Medical School, Ann Arbor, Michigan Pre-Doctoral Research Associate Jun 89-May 94 Iowa State University, Ames, Iowa, Lab Assistant, Veterinary Medical Research Institute Aug 83-May 87 |
 |
University of Colorado School of Law, top 15% of class
Colorado Bar Association
American Association for the Advancement of Science
American Association of Immunologists
University of Colorado: Bernard J. Seeman Scholarship, Don W. Sears Award,
Frederic P. Storke Scholarship
University of Michigan: National Institutes of Health Genetics Training Fellowship,
Thurnau Fellowship, Nomination for Outstanding Teaching
Iowa State University: Phi Beta Kappa, Phi Kappa Phi
Admitted to practice: State of Colorado, 2002
U. S. Patent and Trademark Office, 2003
PATENTS AND PUBLICATIONS:
U.S. Patent No. 6,398,774. Steven J. Penner and Randal W. Sebring, Intranasal Delivery System, issued June 4, 2002
International Patent Application, under the Patent Cooperation Treaty (PCT). 5 April 2001. Inventors Penner Steven J and Sebring Randal W. Intranasal Delivery System. International Publication Number WO 01/23018 A2
Townsend HG, Penner SJ, Watts TC, Cook A, Bogdan J, Haines DM, Griffin S, Chambers T, Holland RE, Whitaker-Dowling P, Youngner JS, Sebring RW. 2001. "Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials" Equine Vet J 2001 Nov;33(7):637-43
Chambers TM, Holland RE, Tudor LR, Townsend HG, Cook A, Bogdan J, Lunn DP, Hussey S, Whitaker-Dowling P, Youngner JS, Sebring RW, Penner SJ, Stiegler GL. 2001. "A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge" Equine Vet J 2001 Nov;33(7):630-6
Townsend H, Cook A, Watts T, Bogdan J, Haines D, Griffin S, Chambers T, Holland R, Whitaker-Dowling P, Youngner J, Penner S, and Sebring R. 1999a. "Efficacy of a cold-adapted, modified-live virus influenza vaccine: a double-blind challenge trial" American Association of Equine Practitioners Proceedings 45:41-42
McCall CA, Stedman KE, Penner SJ, Hunter SW, Bevier DE, Rose BJ, Mondesire R, Wassom DL. 1997. "FcERIa-based measurement of anti-flea saliva IgE in dogs" Clinical Advances: Supplement to Compendium on Continuing Education for the Practicing Veterinarian 19(11):24-28
Stedman K, Weber E, Hunter S, Frank G, Penner SJ, Kwochka K, Wassom D, McCall CM. 1997. "Identification of a major flea salivary allergen relevant to the diagnosis of canine flea allergy dermatitis" XVI International Congress of Allergology and Clinical Immunology, Cancun, Mexico, October 19-24.
Penner SJ, McCall C, Gallegos A, Kehl J, Coeshott C. 1995. "Antigen-specific Immunomodulation: Suppression of Anti-Sulfamethoxazole (SMX) Antibody Responses by SMX-Dextran Multivalent Conjugates" 9th International Congress of Immunology Abstracts:436, no. 2586
Penner SJ, Gallegos A, Kehl J, Coeshott C, McCall C. 1995. "Antigen-specific Immunosuppression: Kinetic Studies of Antibody Secreting Cells after Treatment with Sulfamethoxazole-Dextran Conjugates" Journal of Cellular Biochemistry Abstract Supplement 21A: 104, no. C2-269
Lewis RO, Newman MK, Mossel EC, Penner SJ, Carnathan GW, Barr J. 1995. "Primary toxicological evaluation of CI-0694: acute toxicology in the mouse and radiolabeled disposition studies in the rat" Fundamental and Applied Toxicology, Abstract Issue, 15 (1):195, no 1046
Penner SJ, George J, Browning C, Berry J, Claflin JL. 1994. "Origin of the B Lymphocyte Response to the Phosphocholine of Proteus morganii May Begin with Low Affinity Receptors at High Density" Journal of Cellular Biochemistry Abstract Supplement 18D: 438, no. V751
Penner SJ, George J, Berry J, Claflin JL. 1993. "Effects of mIg Receptor Affinity and Density on the Ability of a B Cell to Function as Antigen Presenting Cell" Journal of Cellular Biochemistry Suppl. 17B:175, no. F222
George J, Penner SJ, Berry J, Claflin JL. 1992. "Effects of Receptor Affinity and Density on the Selection of B Cell Clones" 8th International Congress of Immunology, Budapest, Hungary, August 23-28, 1992:62, no. 14-13
Penner SJ, George J, Berry J, Weber JS, Claflin JL. 1991. "How does Somatic Hypermutation Contribute to Antigen Selection of B Cells with High Affinity Antigen Receptors?" FASEB Journal 5:A608, no. 1380
George J, Penner SJ, Berry J, Claflin JL. 1991. "Requirement for Mutations in Expressed Antibody Gene Suggests a New Role for Somatic Hypermutation" FASEB Journal 5:A608, no. 1381
Penner SJ, George J, Claflin JL. 1995. "Initiation of the Phosphocholine-Specific Response to Proteus morganii: B cell transfectants expressing unmutated VH/VL can respond to stimulation by P. morganii antigen" Journal of Immunology 155:2387-95
George J, Penner SJ, Berry J, Weber JS, Claflin JL. 1993. "Influence of Membrane Ig Receptor Density and Affinity on B Cell Signaling by Antigen: Implications for Affinity Maturation" Journal of Immunology 151:5955-65
Kenny JJ, Moratz CM, Guelde G, O'Connell CD, George J, Dell C, Penner SJ, Weber JS, Berry J, Claflin JL, Longo DL. 1992. "Antigen Binding and Idiotype Analysis of Antibodies Obtained after Electroporation of Heavy and Light Chain Genes Encoding Phosphocholine-specific Antibodies: A Model for T15-Idiotype Dominance" Journal of Experimental Medicine 176:1637-43